Sarepta Therapeutics
SRPT
SRPT
335 hedge funds and large institutions have $7.46B invested in Sarepta Therapeutics in 2018 Q4 according to their latest regulatory filings, with 54 funds opening new positions, 126 increasing their positions, 110 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
10% less first-time investments, than exits
New positions opened: 54 | Existing positions closed: 60
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
25% less capital invested
Capital invested by funds: $9.89B → $7.46B (-$2.43B)
Holders
335
Holding in Top 10
7
Calls
$283M
Puts
$186M
Top Buyers
| 1 | +$156M | |
| 2 | +$130M | |
| 3 | +$115M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$74M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$52.4M |
Top Sellers
| 1 | -$51.7M | |
| 2 | -$31M | |
| 3 | -$29.1M | |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$24.5M |
| 5 |
Jennison Associates
New York
|
-$21.5M |